Follow the 아이큐어 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 아이큐어 has published 60 insider filings. Market capitalisation: €81.1bn. The latest transaction was disclosed on 19 March 2026 (Other). Among the most active insiders: 최영권. All data is openly available.
52
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Fundamental score
Ranked 28,843 of 29,156 companies
7.5
score / 100
Value
10
Quality
5
FCF yld-12%
Earn yld-50%
EV/EBITDA·
ROE-59%
Gross mgn5.3%
Net mgn-40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
아이큐어 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative drugs and therapeutic solutions.